ライフサイエンスコーパス: reduction in blood pressure

1 sses and might confer a clinically important reduction in blood pressure.

2 pplemental oxygen, resulted in a significant reduction in blood pressure.

3 ; P = .009) over and above that predicted by reduction in blood pressure.

4 o hypertensive patients that extend beyond a reduction in blood pressure.

5 also associated with a mild but significant reduction in blood pressure.

6 re patients, along with clinically important reductions in blood pressure.

7 sing rare recessive diseases featuring large reductions in blood pressure.

8 a lower glycemic diet may lead to important reductions in blood pressure.

9 d withdrawal was associated with significant reductions in blood pressure.

10 The blinded trials found no significant reduction in blood pressure (2.9 mm Hg; 95% CI, -0.4 to

11 infarction, or stroke, despite only a modest reduction in blood pressure (23.3 mm Hg systolic).

12 This reduction in blood pressure after transplantation occurr

13 e were observed during nitroprusside-induced reductions in blood pressure: an increase (n = 3), a dec

14 tion for the next 30 months had the greatest reduction in blood pressure and a relative risk for hype

15 A modest, transient reduction in blood pressure and adverse events consisten

16 ages (0.5 and 1 mg/kg) resulted in prolonged reduction in blood pressure and failed to reduce brain l

17 ovements in intermediate outcomes, including reductions in blood pressure and low-density lipoprotein

18 the placebo group, demonstrated significant reductions in blood pressure and pulse rate.

19 Clinically significant long-term reductions in blood pressure and reduced risk for hypert

20 1) during bolus sodium nitroprusside-induced reductions in blood pressure, and significantly reduced

21 ight loss and CPAP may result in incremental reductions in blood pressure as compared with either int

22 If causal, the small reduction in blood pressure associated with breastfeedin

23 pausal symptoms, DRSP/E2 yielded significant reductions in blood pressure (BP).

24 This was associated with a long-term reduction in blood pressure by approximately 15 mm Hg, e

25 g, p < 0.001), NT patients had a significant reduction in blood pressure compared to HT patients.

26 rentiation, although they show a significant reduction in blood pressure due to reduced vascular tone

27 We believe that routine initial reduction in blood pressure (>150 mm Hg) with a combinat

28 We conclude that reductions in blood pressure, heart rate, and insulin le

29 r antagonist (3 mg kg(-1) GR138950) caused a reduction in blood pressure in all fetuses; the hypotens

30 Darusentan provides additional reduction in blood pressure in patients who have not att

31 , there was a 12.8 (SD 17.2)/7.1 (9.9) mm Hg reduction in blood pressure in the valsartan group and a

32 xation of isolated resistance arteries and a reduction in blood pressure in wild-type animals that is

33 utcomes, but were accompanied by substantial reductions in blood pressure in favour of ACE inhibitors

34 This protection is independent of the reduction in blood pressure it causes.

35 n is characterized by hypotension and severe reductions in blood pressure, leading to cardiovascular

36 A reduction in blood pressure lowers the risk.

37 and was associated with a modest additional reduction in blood pressure (</= 5.6 mm Hg).

38 Unequal reductions in blood pressure might account for differenc

39 causes substantial ( approximately 18 mmHg) reductions in blood pressure, opening a novel therapeuti

40 tinal tissue of diabetic rats was not due to reduction in blood pressure or in vascular permeability.

41 indicates that it is likely to be due to the reduction in blood pressure per se, the only recognized

42 nical trial revealed a small but significant reduction in blood pressure, suggesting that the finding

43 mmended doses provides significantly greater reductions in blood pressure than does monotherapy with

44 reater than would be expected from the small reduction in blood pressure that occurred, suggesting th

45 For many overweight individuals, reductions in blood pressure that occur with weight loss

46 (22.5 mg/kg po dose) provided a significant reduction in blood pressure up to 6 h after drug adminis

47 A reduction in blood pressure was associated with aerobic

48 Randomized controlled trials have reported reductions in blood pressure with reductions in sodium i

49 ockers in providing a profound and prolonged reduction in blood pressure without affecting heart rate